Finerenone improves albuminuria in adults with type 1 diabetes and chronic kidney disease
1. In this phase 3 trial involving patients with type 1 diabetes and chronic kidney disease, finerenone was associated with ...
Tag: mineralocorticoid receptor antagonists
Steroidal mineralocorticoid receptor antagonists show little mortality benefit in patients receiving dialysis
1. Cardiovascular mortality and heart failure-related hospitalization were slightly less in the steroidal MRA group, though there was no statistical ...
Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis
1. Cardiovascular mortality and heart failure-related hospitalization were similar in both groups. 2. There was no statistically significant difference between ...
Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart failure with preserved or mildly reduced ejection fraction
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...
#VisualAbstract: Finerenone Reduced Total Worsening Heart Failure Events and Death in Patients With Mildly Reduced or Preserved Ejection Fraction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Low familiarity of guideline-directed heart failure care among patients
1. In this survey of patients with heart failure, most participants were familiar with angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor ...
